Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Kowalewski DJ"'
Autor:
Medici G; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland. gioele.medici@usz.ch.; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland. gioele.medici@usz.ch., Freudenmann LK; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Velz J; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland., Wang SS; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Department of Neurosurgery and Neurotechnology, Eberhard Karls University Tübingen, Tübingen, Germany., Kapolou K; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Roche Diagnostics International Ltd, Rotkreuz, Switzerland., Paramasivam N; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Mühlenbruch L; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany., Kowalewski DJ; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany., Vasella F; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland., Bilich T; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA., Frey BM; Blood Transfusion Service, Swiss Red Cross, Schlieren, Switzerland., Dubbelaar ML; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Quantitative Biology Center (QBiC), Eberhard Karls University Tübingen, 72076, Tübingen, Baden-Württemberg, Germany., Patterson AB; Institute of Immunobiology, Cantonal Hospital St.Gallen, 9007, St. Gallen, Switzerland., Zeitlberger AM; Department of Neurosurgery, Cantonal Hospital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland., Silginer M; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland., Roth P; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland., Weiss T; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland., Wirsching HG; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland., Krayenbühl N; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland., Bozinov O; Department of Neurosurgery, Cantonal Hospital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland., Regli L; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland., Rammensee HG; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany., Rushing EJ; Department of Neuropathology, University Hospital and University of Zurich, Schmelzbergstrasse 12, 8091, Zurich, Switzerland., Sahm F; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Walz JS; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Weller M; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland., Neidert MC; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland.; Department of Neurosurgery, Cantonal Hospital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland.
Publikováno v:
Acta neuropathologica [Acta Neuropathol] 2023 Aug; Vol. 146 (2), pp. 173-190. Date of Electronic Publication: 2023 Jun 27.
Autor:
Kim GB; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA., Fritsche J; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Bunk S; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Mahr A; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Unverdorben F; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Tosh K; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA., Kong H; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA., Maldini CR; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA., Lau C; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA., Srivatsa S; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA., Jiang S; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA., Glover J; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA., Dopkin D; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA., Zhang CX; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA., Schuster H; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Kowalewski DJ; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Goldfinger V; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Ott M; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Fuhrmann D; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Baues M; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Boesmueller H; Institute of Pathology and Neuropathology, Eberhard Karls University, 72076 Tuebingen, Germany., Schraeder C; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Schimmack G; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Song C; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Hoffgaard F; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Roemer M; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Tsou CC; Immatics US, 2201 W. Holcombe Blvd., Suite 205, Houston, TX 77030, USA., Hofmann M; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Treiber T; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Hutt M; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Alten L; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Jaworski M; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Alpert A; Immatics US, 2201 W. Holcombe Blvd., Suite 205, Houston, TX 77030, USA., Missel S; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Reinhardt C; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Singh H; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.; Immatics US, 2201 W. Holcombe Blvd., Suite 205, Houston, TX 77030, USA., Schoor O; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Walter S; Immatics US, 2201 W. Holcombe Blvd., Suite 205, Houston, TX 77030, USA., Wagner C; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Maurer D; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany., Weinschenk T; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.; Immatics US, 2201 W. Holcombe Blvd., Suite 205, Houston, TX 77030, USA., Riley JL; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2022 Aug 31; Vol. 14 (660), pp. eabo6135. Date of Electronic Publication: 2022 Aug 31.
Autor:
Marcu A; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany ana@hla-ligand-atlas.org.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Bichmann L; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany., Kuchenbecker L; Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany., Kowalewski DJ; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany., Freudenmann LK; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany., Backert L; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany., Mühlenbruch L; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany., Szolek A; Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany., Lübke M; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Wagner P; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen, Germany., Engler T; Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen, Germany., Matovina S; Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen, Germany., Wang J; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Hauri-Hohl M; Pediatric Stem Cell Transplantation, University Children's Hospital Zurich, Zurich, Switzerland., Martin R; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Kapolou K; Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland., Walz JS; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital of Tübingen, Tübingen, Germany.; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) and Robert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany., Velz J; Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland., Moch H; Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland., Regli L; Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland., Silginer M; Clinical Neuroscience Center and Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Weller M; Clinical Neuroscience Center and Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Löffler MW; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany.; Department of General, Visceral and Transplant Surgery, University Hospital of Tübingen, Tübingen, Germany.; Department of Clinical Pharmacology, University of Hospital Tübingen, Tübingen, Germany., Erhard F; Institute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Bayern, Germany., Schlosser A; Rudolf Virchow Center - Center for Integrative and Translational Bioimaging, Julius-Maximilians-University Würzburg, Würzburg, Germany., Kohlbacher O; Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany.; Institute for Bioinformatics and Medical Informatics, University of Tübingen, Tübingen, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.; Biomolecular Interactions, Max Planck Institute for Developmental Biology, Tübingen, Germany.; Cluster of Excellence Machine Learning in the Sciences (EXC 2064), University of Tübingen, Tübingen, Germany.; Institute for Translational Bioinformatics, University Hospital Tübingen, Tübingen, Germany., Stevanović S; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany., Rammensee HG; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany., Neidert MC; Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland.; Department of Neurosurgery, Cantonal Hospital St.Gallen, St.Gallen, Switzerland.; Neuroscience Center Zurich (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Apr; Vol. 9 (4).
Autor:
Nelde A; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Bilich T; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Heitmann JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Maringer Y; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Salih HR; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany., Roerden M; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Lübke M; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany., Bauer J; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany., Rieth J; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany., Wacker M; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany., Peter A; Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany., Hörber S; Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany., Traenkle B; NMI, Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Kaiser PD; NMI, Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Rothbauer U; NMI, Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; Pharmaceutical Biotechnology, University of Tübingen, Tübingen, Germany., Becker M; NMI, Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Junker D; NMI, Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Krause G; Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.; TWINCORE GmbH, Centre for Experimental and Clinical Infection Research, a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany.; German Center for Infection Research, Braunschweig, Germany., Strengert M; Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.; TWINCORE GmbH, Centre for Experimental and Clinical Infection Research, a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany., Schneiderhan-Marra N; NMI, Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Templin MF; NMI, Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Joos TO; NMI, Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Kowalewski DJ; Immatics Biotechnologies GmbH, Tübingen, Germany., Stos-Zweifel V; Immatics Biotechnologies GmbH, Tübingen, Germany., Fehr M; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany., Rabsteyn A; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of General Pediatrics, Oncology/Hematology, University Children's Hospital Tübingen, Tübingen, Germany., Mirakaj V; Department of Anesthesia and Intensive Care Medicine, University Hospital Tübingen, Tübingen, Germany., Karbach J; Department of Oncology and Hematology, Krankenhaus Nordwest, Frankfurt, Germany., Jäger E; Department of Oncology and Hematology, Krankenhaus Nordwest, Frankfurt, Germany., Graf M; Applied Bioinformatics, Center for Bioinformatics and Department of Computer Science, University of Tübingen, Tübingen, Germany., Gruber LC; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Rachfalski D; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Preuß B; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Hagelstein I; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Märklin M; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Bakchoul T; Institute for Clinical and Experimental Transfusion Medicine, University Hospital Tübingen, Tübingen, Germany., Gouttefangeas C; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany., Kohlbacher O; Applied Bioinformatics, Center for Bioinformatics and Department of Computer Science, University of Tübingen, Tübingen, Germany.; Institute for Bioinformatics and Medical Informatics, University of Tübingen, Tübingen, Germany.; Biomolecular Interactions, Max-Planck-Institute for Developmental Biology, Tübingen, Germany.; Institute for Translational Bioinformatics, University Hospital Tübingen, Tübingen, Germany., Klein R; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Stevanović S; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany., Rammensee HG; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany., Walz JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.
Publikováno v:
Nature immunology [Nat Immunol] 2021 Jan; Vol. 22 (1), pp. 74-85. Date of Electronic Publication: 2020 Sep 30.
Autor:
Fritsche J; Immatics Biotechnologies GmbH, Tübingen, Germany., Kowalewski DJ; Immatics Biotechnologies GmbH, Tübingen, Germany., Backert L; Immatics Biotechnologies GmbH, Tübingen, Germany., Gwinner F; Immatics Biotechnologies GmbH, Tübingen, Germany., Dorner S; Immatics Biotechnologies GmbH, Tübingen, Germany., Priemer M; Immatics Biotechnologies GmbH, Tübingen, Germany., Tsou CC; Immatics US, Inc, Houston, Texas, USA., Hoffgaard F; Immatics Biotechnologies GmbH, Tübingen, Germany., Römer M; Immatics Biotechnologies GmbH, Tübingen, Germany., Schuster H; Immatics Biotechnologies GmbH, Tübingen, Germany., Schoor O; Immatics Biotechnologies GmbH, Tübingen, Germany., Weinschenk T; Immatics Biotechnologies GmbH, Tübingen, Germany; Immatics US, Inc, Houston, Texas, USA. Electronic address: toni.weinschenk@immatics.com.
Publikováno v:
Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2021; Vol. 20, pp. 100110. Date of Electronic Publication: 2021 Jun 12.
Autor:
Reustle A; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Di Marco M; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany., Meyerhoff C; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Nelde A; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany., Walz JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Winter S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Kandabarau S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Büttner F; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Haag M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Backert L; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany., Kowalewski DJ; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany., Rausch S; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Hennenlotter J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Stühler V; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Scharpf M; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany., Fend F; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany., Stenzl A; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Rammensee HG; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Bedke J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Stevanović S; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. matthias.schwab@ikp-stuttgart.de.; University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de., Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.
Publikováno v:
Genome medicine [Genome Med] 2020 Mar 30; Vol. 12 (1), pp. 32. Date of Electronic Publication: 2020 Mar 30.
Autor:
Lübke M; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany., Spalt S; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium, Partner Site Tübingen, Tübingen, Germany., Kowalewski DJ; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany., Zimmermann C; Institute of Virology, Medical Center University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Bauersfeld L; Institute of Virology, Medical Center University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Nelde A; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Department of Hematology and Oncology, University Hospital Tübingen, Tübingen, Germany., Bichmann L; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Applied Bioinformatics, Center for Bioinformatics and Department of Computer Science, University of Tübingen, Tübingen, Germany., Marcu A; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany., Peper JK; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany., Kohlbacher O; Applied Bioinformatics, Center for Bioinformatics and Department of Computer Science, University of Tübingen, Tübingen, Germany.; Quantitative Biology Center, University of Tübingen, Tübingen, Germany.; Biomolecular Interactions, Max-Planck-Institute for Developmental Biology, Tübingen, Germany.; Institute for Translational Bioinformatics, University Hospital Tübingen, Tübingen, Germany., Walz JS; Department of Hematology and Oncology, University Hospital Tübingen, Tübingen, Germany., Le-Trilling VTK; Institute for Virology, University of Duisburg-Essen, Essen, Germany., Hengel H; Institute of Virology, Medical Center University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Rammensee HG; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium, Partner Site Tübingen, Tübingen, Germany., Stevanović S; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium, Partner Site Tübingen, Tübingen, Germany., Halenius A; Institute of Virology, Medical Center University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2020 Mar 02; Vol. 217 (3).
Autor:
Löffler MW; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Partner Site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Clinical Pharmacology, University Hospital Tübingen, Tübingen, Germany., Nussbaum B; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany., Jäger G; Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.; NGS Competence Center Tübingen (NCCT), University of Tübingen, Tübingen, Germany., Jurmeister PS; Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Budczies J; Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Pereira PL; Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany.; Department of Radiology, Minimally Invasive Therapies and Nuclear Medicine, SLK-Hospital Heilbronn GmbH, Heilbronn, Germany., Clasen S; Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany., Kowalewski DJ; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany., Mühlenbruch L; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Partner Site Tübingen, Tübingen, Germany., Königsrainer I; Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany., Beckert S; Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany., Ladurner R; Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany., Wagner S; Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany., Bullinger F; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Gross TH; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.; Department Medical Oncology and Pneumology, University Hospital Tübingen, Tübingen, Germany., Schroeder C; Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.; NGS Competence Center Tübingen (NCCT), University of Tübingen, Tübingen, Germany., Sipos B; Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany., Königsrainer A; Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Partner Site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Stevanović S; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Partner Site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Denkert C; Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Institute of Pathology, University Hospital Marburg (UKGM) and Philipps-University Marburg, Marburg, Germany., Rammensee HG; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Partner Site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Gouttefangeas C; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Partner Site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Haen SP; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Partner Site Tübingen, Tübingen, Germany.; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.; Department of Oncology, Hematology and Bone Marrow Transplantation With Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Publikováno v:
Frontiers in immunology [Front Immunol] 2019 Nov 19; Vol. 10, pp. 2526. Date of Electronic Publication: 2019 Nov 19 (Print Publication: 2019).
Autor:
Rammensee HG; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany. rammensee@uni-tuebingen.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany. rammensee@uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany. rammensee@uni-tuebingen.de., Wiesmüller KH; EMC microcollections GmbH, Tübingen, Germany., Chandran PA; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Zelba H; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Rusch E; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Gouttefangeas C; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany., Kowalewski DJ; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; Present address: Immatics Biotechnologies GmbH, Tübingen, Germany., Di Marco M; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Haen SP; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital of Tübingen, Tübingen, Germany., Walz JS; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital of Tübingen, Tübingen, Germany., Gloria YC; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Bödder J; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Schertel JM; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany., Tunger A; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz Association/ Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Müller L; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany., Kießler M; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany., Wehner R; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz Association/ Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Schmitz M; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz Association/ Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Jakobi M; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Schneiderhan-Marra N; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Klein R; Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital of Tübingen, Tübingen, Germany., Laske K; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Artzner K; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Backert L; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; Present address: Immatics Biotechnologies GmbH, Tübingen, Germany., Schuster H; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; Present address: Immatics Biotechnologies GmbH, Tübingen, Germany., Schwenck J; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital of Tübingen, Tübingen, Germany.; Werner Siemens Imaging Center, Medical Faculty, University of Tübingen, Tübingen, Germany., Weber ANR; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany., Pichler BJ; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Werner Siemens Imaging Center, Medical Faculty, University of Tübingen, Tübingen, Germany., Kneilling M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Werner Siemens Imaging Center, Medical Faculty, University of Tübingen, Tübingen, Germany.; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany., la Fougère C; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital of Tübingen, Tübingen, Germany., Forchhammer S; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany., Metzler G; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany., Bauer J; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany., Weide B; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany., Schippert W; Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany., Stevanović S; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany., Löffler MW; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany. markus.loeffler@med.uni-tuebingen.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany. markus.loeffler@med.uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tubingen, Germany. markus.loeffler@med.uni-tuebingen.de.; Department of General, Visceral and Transplant Surgery, University Hospital of Tübingen, Tübingen, Germany. markus.loeffler@med.uni-tuebingen.de.; Department of Clinical Pharmacology, University Hospital Tübingen, Tübingen, Germany. markus.loeffler@med.uni-tuebingen.de.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Nov 15; Vol. 7 (1), pp. 307. Date of Electronic Publication: 2019 Nov 15.
Autor:
Murphy JP, Kim Y, Clements DR, Konda P, Schuster H; Department of Immunology, Interfaculty Institute for Cell Biology , University of Tübingen , 72074 Tübingen , Germany.; Immatics Biotechnologies GmbH , 72076 Tübingen , Germany., Kowalewski DJ; Department of Immunology, Interfaculty Institute for Cell Biology , University of Tübingen , 72074 Tübingen , Germany.; Immatics Biotechnologies GmbH , 72076 Tübingen , Germany., Paulo JA; Department of Cell Biology , Harvard Medical School , Boston , Massachusetts 02115 , United States., Cohen AM, Stevanovic S; Department of Immunology, Interfaculty Institute for Cell Biology , University of Tübingen , 72074 Tübingen , Germany., Gygi SP; Department of Cell Biology , Harvard Medical School , Boston , Massachusetts 02115 , United States., Gujar S
Publikováno v:
Journal of proteome research [J Proteome Res] 2019 Jun 07; Vol. 18 (6), pp. 2666-2675. Date of Electronic Publication: 2019 May 29.